From: The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy: an evidence review
Country | Name of subgroup | Cost Year | Currency | Cost of admission/hospitalisation | Cost of medication | All medical | All Direct Costs | First author & publication year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | LCI;UCI | Mean | LCI;UCI | Mean | LCI;UCI | Mean | LCI;UCI | |||||
Germany | Stage 1 DMD Age 1 to 14 | 2013 | Euro (€) | 585 | NR | 172 | NR | NR | NR | 4220 | NR | Schreiber-Katz, 2014 [23] |
Stage 2 DMD Age 3 to 14 | 2013 | 804 | NR | 373 | NR | NR | NR | 7629 | NR | |||
Stage 3 DMD Age 10 to 23 | 2013 | NR | NR | 344 | NR | NR | NR | 11666 | NR | |||
Stage 4 DMD Age 1 to 31 | 2013 | 1540 | NR | 319 | NR | NR | NR | 22989 | NR | |||
Stage 5 DMD Age 11 to 40 | 2013 | 6673 | NR | 550 | NR | NR | NR | 68968 | NR | |||
DMD Age 1 to 42 | 2013 | 1613 | NR | 330 | NR | NR | NR | 19346 | NR | |||
DMD Age 9 to 17 | 2012 | US dollar ($) | 2080 | 1020;4950 | 1020 | 770;2000 | NR | NR | 42360 | 38640;46880 | Landfeldt(a), 2014 [58] | |
Italy | DMD Age 8 to 17 | 2012 | 1420 | 900;2470 | 1550 | 890;4650 | NR | NR | 23920 | 20420;28300 | ||
UK | DMD Age 8 to 17 | 2012 | 2300 | 1500;3720 | 930 | 820;1070 | NR | NR | 54160 | 47310;63510 | ||
US | DMD Age 9 to 17 | 2012 | 2220 | 2220;5050 | 2070 | 1720;2710 | NR | NR | 54270 | 48740;62220 | ||
DMD Age 0 to 64 | 2010 | 10012 | NR | 2144 | NR | 24007 | NR | NR | NR | Larkindale, 2014 [32] |